Table 1. Clinical parameters of EAE progression.
Group of mice | n | Incidence (%) |
Day of Onset (Mean ± SD) |
Maximum Score (Mean ± SD) |
Time to Peak (Mean ± SD) |
Accumulative Score (Mean ± SD) |
---|---|---|---|---|---|---|
Lgals8+/+ | 20 | 85.2 | 13.5 ± 2.8 | 3.4 ± 0.7 | 15.9 ± 3.4 | 28.2 ± 11.9 |
Lgals8-/- | 22 | 86.2 | 12.5 ± 2.6 | 3.6 ± 0.6 | 15.5 ± 3.2 | 40.7 ± 23.2* |
*P < 0.05 comparing accumulative scores between WT and Gal-8 KO mice.